David R. Epstein - Mar 17, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
Director
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Mar 17, 2022
Transactions value $
$0
Form type
4
Date filed
3/21/2022, 04:30 PM
Previous filing
Mar 18, 2022
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXLA Common Stock Options Exercise +1.54K +0.95% 163K Mar 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +50K $0.00 50K Mar 17, 2022 Common Stock 50K $2.51 Direct F2
transaction AXLA Restricted Stock Units Options Exercise $0 -1.54K -100% $0.00* 0 Mar 18, 2022 Common Stock 1.54K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of AXLA common stock.
F2 The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) May 19, 2023 and (ii) the date of the 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service at such time.
F3 The RSUs are fully vested as of the date hereof.